U.S. flag

An official website of the United States government

NM_000152.5(GAA):c.1316T>A (p.Met439Lys) AND Glycogen storage disease

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 12, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000612594.4

Allele description [Variation Report for NM_000152.5(GAA):c.1316T>A (p.Met439Lys)]

NM_000152.5(GAA):c.1316T>A (p.Met439Lys)

Gene:
GAA:alpha glucosidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_000152.5(GAA):c.1316T>A (p.Met439Lys)
HGVS:
  • NC_000017.11:g.80108818T>A
  • NG_009822.1:g.12263T>A
  • NM_000152.5:c.1316T>AMANE SELECT
  • NM_001079803.3:c.1316T>A
  • NM_001079804.3:c.1316T>A
  • NP_000143.2:p.Met439Lys
  • NP_001073271.1:p.Met439Lys
  • NP_001073272.1:p.Met439Lys
  • LRG_673t1:c.1316T>A
  • LRG_673:g.12263T>A
  • NC_000017.10:g.78082617T>A
  • NM_000152.3:c.1316T>A
  • NM_000152.4:c.1316T>A
  • NM_000152.5(GAA):c.1316T>AMANE SELECT
  • NM_001079803.1:c.1316T>A
Protein change:
M439K
Links:
dbSNP: rs747610090
NCBI 1000 Genomes Browser:
rs747610090
Molecular consequence:
  • NM_000152.5:c.1316T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079803.3:c.1316T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079804.3:c.1316T>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Glycogen storage disease
Synonyms:
glycogen storage disorder; Disorder of glycogen metabolism
Identifiers:
MONDO: MONDO:0002412; MedGen: C0017919; OMIM: PS232200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000731983Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Likely pathogenic
(Oct 12, 2017)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

Two new missense mutations of GAA in late onset glycogen storage disease type II.

Park YE, Park KH, Lee CH, Kim CM, Kim DS.

J Neurol Sci. 2006 Dec 21;251(1-2):113-7. Epub 2006 Nov 7.

PubMed [citation]
PMID:
17092519

Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.

Lee JH, Shin JH, Park HJ, Kim SZ, Jeon YM, Kim HK, Kim DS, Choi YC.

Neuromuscul Disord. 2017 Jun;27(6):550-556. doi: 10.1016/j.nmd.2017.03.005. Epub 2017 Mar 10.

PubMed [citation]
PMID:
28433475
See all PubMed Citations (11)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000731983.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (11)

Description

The p.Met439Lys (NM_001079803.1 c.1316T>A) variant in GAA has been reported in a t least 10 compound heterozygous individuals with Pompe disease and segregated w ith disease in one affected sibling (Park 2006, Kobayashi 2010, Park 2013, Lee 2 014, Lee 2017 and Park 2017). This variant has also been reported in ClinVar (Va riation ID#371305), as likely pathogenic. In vitro functional studies provide ev idence that the variant impairs enzymatic activity (Flanagan 2009). This varian t has been identified in 6/14,598 of East Asian chromosomes by the Genome Aggreg ation Database (gnomAD, http://gnomAD.broadinstitute.org; dbSNP rs747610090), th ough this frequency is low enough to be consistent with a recessive carrier freq uency. In summary, although additional studies are required to fully establish i ts clinical significance, the p.Met439Lys variant is likely pathogenic for Pompe disease in an autosomal recessive manner based upon observations in affected in dividuals and functional studies. ACMG/AMP Criteria applied: PS3, PM2, PM3, PP5 (Richards 2015)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Sep 29, 2024